Related Experiment Video
Updated: Jul 3, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Renal metastasis from papillary thyroid microcarcinoma.
Miaw-Jene Liou1, Jen-Der Lin, Mei-Hsin Chung
1Section of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Linkou, Taiwan. lioumj@adm.cgmh.org.tw
Acta Oto-Laryngologica
|April 13, 2005
Summary
Papillary or follicular microcarcinoma, a common thyroid cancer, rarely metastasizes. This report details an unprecedented case of kidney metastasis from thyroid microcarcinoma.
Area of Science:
- Endocrinology
- Oncology
- Nephrology
Background:
- Papillary or follicular microcarcinoma accounts for 10-20% of all thyroid malignancies.
- These tumors typically exhibit slow progression and a favorable prognosis.
- Distant metastasis from thyroid microcarcinoma is rare, usually affecting the lungs or bones.
Observation:
- This report describes a unique case of papillary thyroid microcarcinoma with metastasis to the kidney.
- The patient also presented with a pelvic fracture and pulmonary metastasis.
- Clinically apparent, well-differentiated thyroid carcinoma metastatic to the kidney is exceptionally rare, with only 16 prior cases documented.
Findings:
- The study presents a novel instance of kidney metastasis from thyroid microcarcinoma.
- This case highlights an unusual pattern of distant spread for this type of thyroid cancer.
- Treatment involved total thyroidectomy, radiotherapy, radioactive iodine ablation, and thyroxine suppressive therapy.
Implications:
- Microcarcinoma, despite its small size and generally favorable prognosis, should not be disregarded.
- This case underscores the potential for uncommon metastatic sites, such as the kidney, even from small thyroid tumors.
- The findings suggest a need for vigilance regarding potential distant metastases in patients with thyroid microcarcinoma.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

